Our Corporate Governance Approach
Our commitment to strong Corporate Governance underpins the trust that our investors, employees and institutions have placed in us.
How we are addressing unmet medical needs
Valneva’s Board of Directors, composed of highly skilled members with complementary experiences in the life sciences industry, participates actively in reviewing the Company’s strategic opportunities and setting direction, together with the Executive Committee.
- Anne-Marie Graffin
- Daniéle Guyot-Caparros
- Dr. Gerd Zettlmeissl
- James Edward Connolly
- James Sulat
- Dr. Kathrin U Jansen
- Thomas Lingelbach
Valneva’s Executive Committee is a highly experienced international team with diverse backgrounds and expertise. Our Executive Committee is currently comprised of eight members:
- Thomas Lingelbach – Chief Executive Officer, Member of the Board of Directors
- Peter Bühler – Chief Financial Officer
- Vincent Dequenne – Chief Operating Officer
- Juan Carlos Jaramillo, MD – Chief Medical Officer
- Dipal Patel – Chief Commercial Officer
- Petra Pesendorfer – Chief People Officer
- Dr. Hanneke Schuitemaker, PhD – Chief Scientific Officer
- Kendra Wergin – General Counsel